A PHP Error was encountered

Severity: 4096

Message: Object of class stdClass could not be converted to string

Filename: libraries/Parser.php

Line Number: 101

A PHP Error was encountered

Severity: 4096

Message: Object of class stdClass could not be converted to string

Filename: libraries/Parser.php

Line Number: 101

A PHP Error was encountered

Severity: 4096

Message: Object of class stdClass could not be converted to string

Filename: libraries/Parser.php

Line Number: 101

Events | PlasCarb

Graphene Connect – Biomedical Technologies

Grenoble, France


Meet your future graphene collaborators at Graphene Connect – Biomedical Technologies. Listen to state-of-the-art research, industry representatives giving their view of graphene in biosensor and implant applications. Engage in group discussions and networking.

​The afternoon of 23th February is devoted to biosensor applications, while the morning of 24th will focus on implants.

The program includes popular presentation (general overview) on state-of-the art research by the work package leaders presenting the plan for the coming years, industry perspectives by industry representatives and investors. Building on the presentations, there will be moderated group discussions with the possibility of representatives across industry sectors to interact with each other as well as with researchers. The aim is to strengthen collaboration throughout the value chain from researchers, to component, system producers and end-users. 

Graphene Connect is an enabling instrument of the Graphene Flagship to engage in a direct dialogue and envision new collaborations between European companies and academics working in applied research, innovation and development related to graphene and other 2D materials.

Graphene Connect industry series provides an excellent opportunity to get an overview on research activities within the Graphene Flagship, as well as industry demands.
 

Confirmed speakers:

Kostas Kostarelos, University of Manchester
Lubomir Gradinarsky, Astra Zeneca
Daniel Chew, Glaxo Smith Kline
Clemens Boucsein, Multichannel Systems

READ MORE